Successful treatment of acquired factor VIII deficiency in a child using activated factor VII concentrates: Case report and review of the literature

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 7, 2003, Pages 578-580

  Bruggers, Carol S ^a   Bleak, Shirley ^b  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acquired factor VIII deficiency; Acquired hemophilia; Activated factor VII concentrates

Indexed keywords

BLOOD CLOTTING FACTOR 7 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; CORTICOSTEROID; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; BLEEDING; BLOOD CLOTTING; CASE REPORT; COMPARTMENT SYNDROME; FASCIOTOMY; FEMALE; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; FACTOR VIIA; FEMALE; HEMOPHILIA A; HUMANS; TREATMENT OUTCOME;

EID: 0037972713     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200307000-00018     Document Type: Article

References (19)

1. Lottenberg R, Kentro TB, Kitchens CS. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med. 1987;147:1077-1081.
2. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost. 1981;45:200-203.
3. Dykes AC, Walker ID, Lowe GD, et al. Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia. 2001;7:160-163.
4. Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood. 1993;81:1513-1520.
5. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired F VIII:C inhibitors. Br J Haematol. 1981;48:635-642.
6. Morrison AE, Ludlam CA. Acquired haemophilia and its management. Br J Haematol. 1995;89:231-236.
7. Kashyap R, Choudhry VP, Mahapatra M, et al. Postpartum acquired haemophilia: clinical recognition and management. Haemophilia. 2001;7:327-330.
8. Grunewald M, Beneke H, Guthner C, et al. Acquired haemophilia: experiences with a standardized approach. Haemophilia. 2001;7:164-169.
9. Mazzucconi MG, Bizzoni L, Giorgi A, et al. Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone. Haemophilia. 2001;7:422-427.
10. Kobrinsky NL, Stegman D, Sjolander D. Management of spontaneous inhibitors in children with porcine factor VIII. Haemophilia. 2002;8(Suppl 1):1-4.
11. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost. 1997;78:1463-1467.
12. Michiels JJ, Hamulyak K, Nieuwenhuis HK, et al. Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor. Eur J Haematol. 1997;59:105-109.
13. Schwartz RS, Gabriel DA, Aledort LM, et al. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood. 1995;86:797-804.
14. Negrier C, Goudemand J, Sultan Y, et al. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Thromb Haemost. 1997;77:1113-1119.
15. Lusher JM. Thrombogenicity associated with factor IX complex concentrates. Semin Hematol. 1991;28:3-5.
16. O'Connell N, McMahon C, Smith J, et al. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors. Br J Haematol. 2002;116:632-635.
17. Van't Veer C, Mann KG. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost. 2000;26:367-372.
18. Shapiro AD. Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors. Semin Thromb Hemost. 2000;26:413-419.
19. Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost. 2000;26:385-391.